CCL21 and myasthenia gravis: This correlation was confirmed by functional in vitro experiments in TECs [85], suggesting that the already known CCL21 overexpression in MG thymuses [105] may be a consequence of miR-7-5p down-regulation, and hence that miR-7-5p dysregulation may contribute to GC development and hyperplastic changes in the thymus of MG patients.